Wall St Engine(@wallstengine):QUANTUM COMPUTING $QUBT Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $9.5M (Est. $7.2M) 🟢; +2374% YoY 🔹 EPS: -$0.07 (Est. -$0.05) 🔴 🔹 Gross Margin: 4.5% 🔹 Net Loss: $15.1M Other Q3 Metrics: 🔹 Cash & Investments: ~$1.3B 🔹 Contract Backlog: ~$39.1M Announcements: 🔹 INmune Bio: QCi’s first commercial customer in pharma and biotech Key Updates: 🔹 Derivative Liability Fair Value: $458 thousand gain 🔹 Acquisition-related Expenses: ~$1.0M Comments: 🔸 “We're encouraged by our progress, but recognize there's considerable work ahead. Our priorities are clear: growing our commercial business, scaling manufacturing and advancing our quantum roadmap.”

2026.11.09 21:10

QUANTUM COMPUTING $QUBT Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $9.5M (Est. $7.2M) 🟢; +2374% YoY 🔹 EPS: -$0.07 (Est. -$0.05) 🔴 🔹 Gross Margin: 4.5% 🔹 Net Loss: $15.1M Other Q3 Metrics: 🔹 Cash & Investments: ~$1.3B 🔹 Contract Backlog: ~$39.1M Announcements: 🔹 INmune Bio: QCi’s first commercial customer in pharma and biotech Key Updates: 🔹 Derivative Liability Fair Value: $458 thousand gain 🔹 Acquisition-related Expenses: ~$1.0M Comments: 🔸 “We're encouraged by our progress, but recognize there's considerable work ahead. Our priorities are clear: growing our commercial business, scaling manufacturing and advancing our quantum roadmap.”